Skip to content

Fluoroscopic vs Ultrasound Guided Sacroiliac (SI) Joint Injection

Fluoroscopic vs Ultrasound Guided Sacroiliac (SI) Joint Injection

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05235295
Enrollment
60
Registered
2022-02-11
Start date
2022-04-01
Completion date
2022-10-15
Last updated
2022-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Chronic

Brief summary

The investigators aimed to evaluate the effectiveness of intra-articular sacroiliac joint injection under fluoroscopy versus ultrasound guidance

Interventions

PROCEDUREUltrasound-guided sacroiliac joint injection

Using ultrasound the sacral hiatus in transverse position was identified. Then, sliding laterally and cephalad in transverse position, the posterior superior iliac spine and the posterior sacroiliac joint were identified. The needle was advanced toward the posterior joint space from medial to lateral, using an in-plane technique.

PROCEDUREFlouroscopy-guided sacroiliac joint injection

Using anterior posterior and contralateral oblique view the posterior joint line and inferior joint margin were identified and a needle was advanced at the point the posterior inferior joint line was most clearly seen.

Sponsors

Diskapi Teaching and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Low back and/or gluteal pain without radicular extension for more than 3 months * Tenderness over the SI joint * Pain score \> 3 by Visual Analogue Scale

Exclusion criteria

* Malignancy * Generalized or local infection * Coagulopathy * Allergy to drugs to be injected

Design outcomes

Primary

MeasureTime frameDescription
Reduction in painChange from baseline pain score at 3 monthsPain assessment will be performed using the Visual Analogue Scale (VAS) score (0 = no pain, 10 = the most severe pain felt).

Secondary

MeasureTime frameDescription
Oswestry Disability Index (ODI)Baseline to 3 months post-procedureMean Change from Baseline in functional disability scores based on Oswestry Disability Index. 0% to 20% indicate minimal disability, 21% to 40% indicate moderate disability, 41%-60% indicates severe disability, 61%-80% means crippled and 81%-100% indicates that the patient is either bed-bound or exaggerating his/her symptoms.
Patient satisfaction Questionnairebaseline to 3 months post-procedureSatisfaction was measured on a 1 to 5 scale,Using score: 5-Excellent, 4-Very Good, 3-Good, 2-Fair, and 1-Poor
Quantitative analgesic questionnaireat 3 months post-procedureA tool designed to record patient-reported pain medication use, create scores to quantify and compare it and track changes in analgesic drug use over time. A higher score indicates higher pain medication use
Procedure timeIntraoperativeProcedure time was measured using a stopwatch. It was defined as the time from the start of the procedure, the initial image was obtained or first probe placement, until the end of the procedure defined as;transforaminal needle placement was seen clearly.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026